EGFR and lung cancer: The review study demonstrates that male patients harbor more uncommon EGFR mutations compared with common mutations among primary lung cancer patients in China, and patients with uncommon mutations might be unfavorable responses to EGFR-TKIs (the shorter PFS) compared with those with common mutations [68].